Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder

[1]  R. Reid,et al.  ADHD Rating Scale-IV: School Checklist , 2018 .

[2]  G. Salmon,et al.  Attention deficit hyperactivity disorder. , 2018, British journal of hospital medicine.

[3]  I. Kohane,et al.  Integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co-morbidities , 2016, Genome Biology.

[4]  J. Qian,et al.  Correlative study of peripheral ATP1A1 gene expression level to anxiety severity score on major depressive disorder patients , 2016, Journal of basic and clinical physiology and pharmacology.

[5]  Ebru Fındıklı,et al.  Serum levels of G protein-coupled estrogen receptor 1 (GPER1) in drug-naive patients with generalized anxiety disorder , 2016, Psychiatry Research.

[6]  Wim E Crusio,et al.  Transcriptome analysis of genes and gene networks involved in aggressive behavior in mouse and zebrafish , 2016, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[7]  Benjamin A. Logsdon,et al.  Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia , 2016, Nature Neuroscience.

[8]  Jingyu Liu,et al.  Correspondence of DNA Methylation Between Blood and Brain Tissue and Its Application to Schizophrenia Research. , 2016, Schizophrenia bulletin.

[9]  G. Hardiman,et al.  Acute stress enhances the expression of neuroprotection- and neurogenesis-associated genes in the hippocampus of a mouse restraint model , 2016, Oncotarget.

[10]  C. Cardozo,et al.  The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer’s Disease and Spinal Cord Injury , 2016, Front. Mol. Neurosci..

[11]  Timothy C. Bates,et al.  Examining non-syndromic autosomal recessive intellectual disability (NS-ARID) genes for an enriched association with intelligence differences☆ , 2016, Intelligence.

[12]  Á. Carracedo,et al.  Female patient with autistic disorder, intellectual disability, and co‐morbid anxiety disorder: Expanding the phenotype associated with the recurrent 3q13.2–q13.31 microdeletion , 2015, American journal of medical genetics. Part A.

[13]  B. Franke,et al.  Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence , 2015, Translational Psychiatry.

[14]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[15]  D. Horn,et al.  A Novel Oculo-Skeletal syndrome with intellectual disability caused by a particular MAB21L2 mutation. , 2015, European journal of medical genetics.

[16]  M. Vinberg,et al.  A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder , 2015, Translational Psychiatry.

[17]  P. Falkai,et al.  Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains , 2015, European Archives of Psychiatry and Clinical Neuroscience.

[18]  P. Sullivan,et al.  Genome-Wide Meta-Analysis of Longitudinal Alcohol Consumption Across Youth and Early Adulthood , 2015, Twin Research and Human Genetics.

[19]  Young Jae Woo,et al.  Reciprocal Relationship between Head Size, an Autism Endophenotype, and Gene Dosage at 19p13.12 Points to AKAP8 and AKAP8L , 2015, PloS one.

[20]  L. Sun,et al.  Gene expression profiling in peripheral blood mononuclear cells of early-onset schizophrenia , 2015, Genomics data.

[21]  Joana S. Ferreira,et al.  GluN2B-Containing NMDA Receptors Regulate AMPA Receptor Traffic through Anchoring of the Synaptic Proteasome , 2015, The Journal of Neuroscience.

[22]  B. Gener,et al.  Integrated analysis of whole-exome sequencing and transcriptome profiling in males with autism spectrum disorders , 2015, Molecular Autism.

[23]  W. Kao,et al.  Relative performance of gene- and pathway-level methods as secondary analyses for genome-wide association studies , 2015, BMC Genetics.

[24]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[25]  Stephan J Sanders,et al.  The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment , 2015, Nature Communications.

[26]  L. Kiemeney,et al.  Case–Control Genome-Wide Association Study of Persistent Attention-Deficit Hyperactivity Disorder Identifies FBXO33 as a Novel Susceptibility Gene for the Disorder , 2015, Neuropsychopharmacology.

[27]  Gustavo Glusman,et al.  Rare variants in neuronal excitability genes influence risk for bipolar disorder , 2015, Proceedings of the National Academy of Sciences.

[28]  B. Crespo-Facorro,et al.  Schizophrenia Gene Expression Profile Reverted to Normal Levels by Antipsychotics , 2015, The international journal of neuropsychopharmacology.

[29]  T. Cummins,et al.  The molecular genetic architecture of attention deficit hyperactivity disorder , 2015, Molecular Psychiatry.

[30]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[31]  Laura J. Scott,et al.  Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways , 2015, Nature Neuroscience.

[32]  S. Scherer,et al.  Using extended pedigrees to identify novel autism spectrum disorder (ASD) candidate genes , 2015, Human Genetics.

[33]  Suhua Chang,et al.  Molecular genetic studies of ADHD and its candidate genes: A review , 2014, Psychiatry Research.

[34]  J. García-Sevilla,et al.  FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: Basal contents and effects of psychotropic treatments , 2014, Neuroscience.

[35]  A. Pillai,et al.  Ubiquitin-proteasome dependent degradation of GABAAα1 in autism spectrum disorder , 2014, Molecular Autism.

[36]  C. Schwarzer,et al.  GPER1 (GPR30) knockout mice display reduced anxiety and altered stress response in a sex and paradigm dependent manner , 2014, Hormones and Behavior.

[37]  S. Scherer,et al.  Biological Overlap of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: Evidence From Copy Number Variants , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[38]  M C O'Donovan,et al.  Copy number variation in schizophrenia in Sweden , 2014, Molecular Psychiatry.

[39]  John J. Foxe,et al.  Mosaic Epigenetic Dysregulation of Ectodermal Cells in Autism Spectrum Disorder , 2014, bioRxiv.

[40]  Christopher D. Brown,et al.  Genomic View of Bipolar Disorder Revealed by Whole Genome Sequencing in a Genetic Isolate , 2014, PLoS genetics.

[41]  Simon C. Potter,et al.  A Genome-wide Association Analysis of a Broad Psychosis Phenotype Identifies Three Loci for Further Investigation , 2014, Biological Psychiatry.

[42]  M. Pirinen,et al.  A Genome-wide Association Analysis of a Broad Psychosis Phenotype Identifies Three Loci for Further Investigation , 2014, Biological Psychiatry.

[43]  A. Pillai,et al.  Glucocorticoid Regulates Parkin Expression in Mouse Frontal Cortex: Implications in Schizophrenia , 2014, Current neuropharmacology.

[44]  Joseph T. Glessner,et al.  Identification of rare DNA sequence variants in high-risk autism families and their prevalence in a large case/control population , 2014, Molecular Autism.

[45]  Eliona Tsefou,et al.  Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer's disease mouse model , 2013, Aging cell.

[46]  John P. Rice,et al.  A genome-wide association study of alcohol-dependence symptom counts in extended pedigrees identifies C15orf53 , 2013, Molecular Psychiatry.

[47]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[48]  B. Franke,et al.  AKAPs integrate genetic findings for autism spectrum disorders , 2013, Translational Psychiatry.

[49]  P. Wong,et al.  Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients , 2013, Translational Psychiatry.

[50]  M. Daly,et al.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.

[51]  V. Haroutunian,et al.  Dysfunction of the Ubiquitin Proteasome and Ubiquitin-Like Systems in Schizophrenia , 2013, Neuropsychopharmacology.

[52]  N. Wray,et al.  A mega-analysis of genome-wide association studies for major depressive disorder , 2013, Molecular Psychiatry.

[53]  K. Zito,et al.  Breaking It Down: The Ubiquitin Proteasome System in Neuronal Morphogenesis , 2013, Neural plasticity.

[54]  Stephan Ripke,et al.  Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. , 2013, The American journal of psychiatry.

[55]  S Cichon,et al.  Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder , 2012, Molecular Psychiatry.

[56]  J. Schweitzer,et al.  Correlations of gene expression with ratings of inattention and hyperactivity/impulsivity in tourette syndrome: a pilot study , 2012, BMC Medical Genomics.

[57]  J. Ramos-Quiroga,et al.  Validez de criterio y concurrente de la versión española de la Conners Adult ADHD Diagnostic Interview for DSM-IV , 2012 .

[58]  R. Handsaker,et al.  Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder , 2012, Molecular Psychiatry.

[59]  J. Marchini,et al.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.

[60]  Zhen Yan,et al.  Repeated Stress Causes Cognitive Impairment by Suppressing Glutamate Receptor Expression and Function in Prefrontal Cortex , 2012, Neuron.

[61]  Nicholas J. Schork,et al.  Age-Dependent Brain Gene Expression and Copy Number Anomalies in Autism Suggest Distinct Pathological Processes at Young Versus Mature Ages , 2012, PLoS genetics.

[62]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[63]  R. Schekman,et al.  Ubiquitin-dependent regulation of COPII coat size and function , 2012, Nature.

[64]  B. Franke,et al.  The genetics of attention deficit/hyperactivity disorder in adults, a review , 2011, Molecular Psychiatry.

[65]  J. Leek,et al.  Temporal dynamics and genetic control of transcription in the human prefrontal cortex , 2011, Nature.

[66]  Wei Chen,et al.  Deep sequencing reveals 50 novel genes for recessive cognitive disorders , 2011, Nature.

[67]  Peilin Jia,et al.  Gene set analysis of genome-wide association studies: methodological issues and perspectives. , 2011, Genomics.

[68]  K. Iwamoto,et al.  Survey of the effect of genetic variations on gene expression in human prefrontal cortex and its application to genetics of psychiatric disorders , 2011, Neuroscience Research.

[69]  Chia-Hsiang Chen,et al.  Clinical and molecular characterization of a transmitted reciprocal translocation t(1;12)(p32.1;q21.3) in a family co-segregating with mental retardation, language delay, and microcephaly , 2011, BMC Medical Genetics.

[70]  N. Datson,et al.  Hippocampal CA1 region shows differential regulation of gene expression in mice displaying extremes in behavioral sensitization to amphetamine: relevance for psychosis susceptibility? , 2011, Psychopharmacology.

[71]  John H. Byrne,et al.  Protein degradation and memory formation , 2011, Brain Research Bulletin.

[72]  Yang Wang,et al.  Common SNPs in CSF2RB are associated with major depression and schizophrenia in the Chinese Han population , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[73]  B. Franke,et al.  Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. , 2011, The American journal of psychiatry.

[74]  T. Shaikh,et al.  Rare structural variation of synapse and neurotransmission genes in autism , 2011, Molecular Psychiatry.

[75]  G. Churchill,et al.  Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models , 2010, Molecular Psychiatry.

[76]  K. Strimbu,et al.  What are biomarkers? , 2010, Current opinion in HIV and AIDS.

[77]  H. Stefánsson,et al.  Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis , 2010, BDJ.

[78]  Rafael A. Irizarry,et al.  A framework for oligonucleotide microarray preprocessing , 2010, Bioinform..

[79]  Susanne Walitza,et al.  Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[80]  Margaret A. Pericak-Vance,et al.  A genome-wide scan for common alleles affecting risk for autism , 2010, Human molecular genetics.

[81]  P. Visscher,et al.  A versatile gene-based test for genome-wide association studies. , 2010, American journal of human genetics.

[82]  A. Hegde.  The ubiquitin-proteasome pathway and synaptic plasticity. , 2010, Learning & memory.

[83]  Zhi-Yong Peng,et al.  RNF122: A novel ubiquitin ligase associated with calcium-modulating cyclophilin ligand , 2010, BMC Cell Biology.

[84]  Stephen J Glatt,et al.  Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: Convergent pathway analysis findings from two independent samples , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[85]  A. Hoischen,et al.  Severe Progressive Autism Associated with Two de novo Changes: A 2.6-Mb 2q31.1 Deletion and a Balanced t(14;21)(q21.1;p11.2) Translocation with Long-Range Epigenetic Silencing of LRFN5 Expression , 2010, Molecular Syndromology.

[86]  W. Brown,et al.  Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individuals. , 2009, Life sciences.

[87]  John P. Rice,et al.  Genome-wide association study of bipolar disorder in European American and African American individuals , 2009, Molecular Psychiatry.

[88]  I. Waldman,et al.  Candidate gene studies of ADHD: a meta-analytic review , 2009, Human Genetics.

[89]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[90]  R. Ebstein,et al.  Association Between Sodium- and Potassium-Activated Adenosine Triphosphatase α Isoforms and Bipolar Disorders , 2009, Biological Psychiatry.

[91]  Robert T. Schultz,et al.  Autism genome-wide copy number variation reveals ubiquitin and neuronal genes , 2009, Nature.

[92]  Robert T. Schultz,et al.  Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.

[93]  Jack A. Taylor,et al.  SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies , 2009, Nucleic Acids Res..

[94]  N. Craddock,et al.  Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk , 2009, Molecular Psychiatry.

[95]  Hwan‐Ching Tai,et al.  Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction , 2008, Nature Reviews Neuroscience.

[96]  A. Fanous,et al.  Association study of CSF2RB with schizophrenia in Irish family and case – control samples , 2008, Molecular Psychiatry.

[97]  D. Stephan,et al.  A survey of genetic human cortical gene expression , 2007, Nature Genetics.

[98]  D. M. Lyons,et al.  Stress-induced changes in primate prefrontal profiles of gene expression , 2007, Molecular Psychiatry.

[99]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[100]  M. Ehlers,et al.  Emerging Roles for Ubiquitin and Protein Degradation in Neuronal Function , 2007, Pharmacological Reviews.

[101]  D. Rubinsztein,et al.  The roles of intracellular protein-degradation pathways in neurodegeneration , 2006, Nature.

[102]  D. James,et al.  Molecular Dissection of the Munc18c/Syntaxin4 Interaction: Implications for Regulation of Membrane Trafficking , 2006, Traffic.

[103]  Michael Q. Zhang,et al.  An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. , 2006, Human molecular genetics.

[104]  M. Webster,et al.  Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes , 2006, Molecular Psychiatry.

[105]  Danielle N. Pappas.  ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation , 2006 .

[106]  Charles M Perou,et al.  Evaluating the comparability of gene expression in blood and brain , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[107]  D. Nyholt.  A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. , 2004, American journal of human genetics.

[108]  B. Dubois,et al.  Subtle cognitive impairment but no dementia in patients with spastin mutations. , 2003, Archives of neurology.

[109]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[110]  Molecular genetic delineation of a deletion of chromosome 13q12→q13 in a patient with autism and auditory processing deficits , 2003, Cytogenetic and Genome Research.

[111]  K. Broadie,et al.  The Ubiquitin Proteasome System Acutely Regulates Presynaptic Protein Turnover and Synaptic Efficacy , 2003, Current Biology.

[112]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[113]  Nobutaka Hattori,et al.  Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.

[114]  C. Pickart,et al.  Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[115]  P. Wender,et al.  The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. , 1993, The American journal of psychiatry.

[116]  D. Sheehan,et al.  The Anxiety Disease , 1984 .

[117]  P. Guest,et al.  Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival , 2011, Proteomics.

[118]  M. Biasi,et al.  The Ubiquitin–Proteasome System Regulates the Stability of Neuronal Nicotinic Acetylcholine Receptors , 2009, Journal of Molecular Neuroscience.

[119]  X. Estivill,et al.  Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB , 2009, Molecular Psychiatry.

[120]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[121]  Conners Ck.  The computerized continuous performance test. , 1985 .

[122]  C. Conners.  The computerized continuous performance test. , 1985, Psychopharmacology bulletin.

[123]  R. Amann,et al.  Predictive Identification of Exonic Splicing Enhancers in Human Genes , 2022 .

[124]  J. Qian,et al.  Central European Journal of Biology , 2022 .